complications between the 2 groups. The rate of pure laparosocopy (15.8%) and the robotic-assisted procedure (19.5%). Our conclusion was that pure laparoscopic extra-peritoneal radical prostatectomy is equivalent to the robotic-assisted procedure in a centre experienced in laparoscopic techniques.
The current review is a welcome addition to the comparative literature regarding the status of minimally-invasive techniques against the well-established gold standard of open surgery. Tooher et al., in their comprehensive review of this topic, concluded that any conclusions that can be drawn from these comparisons are limited by the nature of the available data (4). Well performed, randomized, controlled trials are urgently required to provide stronger evidence up and the use of internationally validated measures of functional outcomes are essential.
Systemic Treatment for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Laparoscopic Radical Cystectomy
To the Editor, The standard treatment for invasive transipatterns can be found in this disease (1). urologic surgery to reproduce traditional operations in the endoscopic environment in order to minimize morbidity without compromising cancer outcomes.
ceived as a procedure that could actually diminishes nowadays: Mortality should not be higher than 2% lower than 10% overall and 15% in pT3 or pT4 and the median number of pelvic nodes retrieved in the ously, orthotopic neobladder has become a surgical standard that improved the quality of life of these patients (3).
The surgical technique for radical cystectomy every case (2): advanced tumors. 2. Minimal blood loss with early vascular control of superior and inferior vesical arteries.
Nowadays, the best outcomes in bladder cancer therapeutics are probably obtained when there is radical cystectomy in a systemic treatment setting.
tages in patients with bladder cancer because it offers 5% of survival and 14% decreased risk of associated disease mortality (1). One might argue that two third of the patients would be treated without any response and survival advantage may be outweighed by potential treatment morbidity, with an important number of pahowever, selection of the population incorporated in the protocols should address this issue. in the last two decades and advances accomplished in the management of pulmonary, cardiovascular and hemodynamic effects of pneumoperitoneum allows offering laparoscopy as a safe alternative for these has been reported with perioperative and functional outcomes comparable with open surgery and adequate one, and perhaps offer a more effective treatment for swers in this matter and this constitutes our proposal for laparoscopy teams and medical oncologist, to unite the main consideration for surgery in bladder carcinoma was the precarious health of this patient's popu-(6) have reported important percentages of smokers (65%), hypertension (59%) and cardiac disease (17%) we know that physiological changes incurred as a result of pneumoperitoneum have minimal adverse scopic surgery; therefore, in the setting of systemic therapy. Minimizing operative trauma becomes even more important for these patients. To open the path, there is need for clinical protocols incorporating these therapeutical options in order to address initially the morbidity and mortality while keeping in mind the oncological safety.
Take Home Message
The combination of two effective treatments -medical and surgical-would probably offer a great advantage to patients with invasive bladder cancer. morbidity surgical option to patients who have previously received chemotherapy for invasive bladder carcinoma.
